These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 15597954)

  • 1. [Development of microchips for the detection of mutations of HIV-1 variability to protease inhibitors and the usage results].
    Rudinskiĭ NI; Mikhaĭlovich VM; Donnikov MIu; Lapa SA; Sukhanova AL; Kazennova EV; Bobkov AF; Zasedatelev AS; Pokrovskiĭ VV; Mirzabekov AD
    Vopr Virusol; 2004; 49(6):10-5. PubMed ID: 15597954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diversity of human immunodeficiency virus type 1 subtype A and CRF03_AB protease in Eastern Europe: selection of the V77I variant and its rapid spread in injecting drug user populations.
    Roudinskii NI; Sukhanova AL; Kazennova EV; Weber JN; Pokrovsky VV; Mikhailovich VM; Bobkov AF
    J Virol; 2004 Oct; 78(20):11276-87. PubMed ID: 15452247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of human immunodeficiency virus type 1 subtype C on drug resistance mutations in patients from Botswana failing a nelfinavir-containing regimen.
    Doualla-Bell F; Avalos A; Gaolathe T; Mine M; Gaseitsiwe S; Ndwapi N; Novitsky VA; Brenner B; Oliveira M; Moisi D; Moffat H; Thior I; Essex M; Wainberg MA
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2210-3. PubMed ID: 16723586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The genetic variability of the protease-encoding region in HIV-1 A isolates and in CRF03_AB recombinants as observed in the CIS territory].
    Sukhanova AL; Kazennova EV; Rudinskiĭ NI; Mikhaĭlovich VM; Griadunov DA; Budilov AV; Bulavkina MA; Weber JN; Pokrovskiĭ VV; Bobkov AF
    Vopr Virusol; 2004; 49(6):4-9. PubMed ID: 15597953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diverse pattern of protease inhibitor resistance mutations in HIV-1 infected patients failing nelfinavir.
    Svedhem V; Lindkvist A; Bergroth T; Knut L; Sönnerborg A
    J Med Virol; 2005 Aug; 76(4):447-51. PubMed ID: 15977242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational patterns and correlated amino acid substitutions in the HIV-1 protease after virological failure to nelfinavir- and lopinavir/ritonavir-based treatments.
    Garriga C; Pérez-Elías MJ; Delgado R; Ruiz L; Nájera R; Pumarola T; Alonso-Socas Mdel M; García-Bujalance S; Menéndez-Arias L;
    J Med Virol; 2007 Nov; 79(11):1617-28. PubMed ID: 17854027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence variability in p6 gag protein and gag/pol coevolution in human immunodeficiency type 1 subtype F genomes.
    Rossi AH; Rocco CA; Mangano A; Sen L; Aulicino PC
    AIDS Res Hum Retroviruses; 2013 Jul; 29(7):1056-60. PubMed ID: 23458243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy.
    Brandin E; Lindborg L; Gyllensten K; Broström C; Hagberg L; Gisslen M; Tuvesson B; Blaxhult A; Albert J
    AIDS Res Hum Retroviruses; 2003 Jul; 19(7):543-50. PubMed ID: 12908931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An HIV type 1 subtype A strain of low genetic diversity continues to spread among injecting drug users in Russia: study of the new local outbreaks in Moscow and Irkutsk.
    Bobkov A; Kazennova E; Khanina T; Bobkova M; Selimova L; Kravchenko A; Pokrovsky V; Weber J
    AIDS Res Hum Retroviruses; 2001 Feb; 17(3):257-61. PubMed ID: 11177409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of HIV-1 protease mutations A71V/T and T74S on M89I/V-mediated protease inhibitor resistance in subtype G isolates.
    Gonzalez LM; Santos AF; Abecasis AB; Van Laethem K; Soares EA; Deforche K; Tanuri A; Camacho R; Vandamme AM; Soares MA
    J Antimicrob Chemother; 2008 Jun; 61(6):1201-4. PubMed ID: 18356151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of polymorphisms at position 89 in the HIV-1 protease gene in the development of drug resistance to HIV-1 protease inhibitors.
    Martinez-Cajas JL; Wainberg MA; Oliveira M; Asahchop EL; Doualla-Bell F; Lisovsky I; Moisi D; Mendelson E; Grossman Z; Brenner BG
    J Antimicrob Chemother; 2012 Apr; 67(4):988-94. PubMed ID: 22315096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of mutations during replication of an HIV library containing combinations of selected protease mutations.
    Song W; Maeda Y; Tenpaku A; Harada S; Yusa K
    Antiviral Res; 2004 Mar; 61(3):173-80. PubMed ID: 15168798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular genetic characteristics of HIV-1 variants circulating in Cherepovets, Vologda region: the second case of the epidemic outbreak caused by the recombinant gagAenvB].
    Kazennova EV; Bronnikova AV; Kuzin SN; Kirillova IL; Ershova ON; Afanas'eva LR; Bobkova MR
    Vopr Virusol; 2008; 53(5):23-7. PubMed ID: 19069789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV type 1 genetic diversity and genotypic drug susceptibility in the Republic of Moldova.
    Pandrea I; Descamps D; Collin G; Robertson DL; Damond F; Dimitrienco V; Gheorghita S; Pecec M; Simon F; Brun-Vézinet F; Apetrei C
    AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1297-304. PubMed ID: 11559431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the HIV-1 protease nelfinavir resistance mutation D30N in subtypes B and C through molecular dynamics simulations.
    Soares RO; Batista PR; Costa MG; Dardenne LE; Pascutti PG; Soares MA
    J Mol Graph Model; 2010 Sep; 29(2):137-47. PubMed ID: 20541446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assay.
    Kapoor A; Jones M; Shafer RW; Rhee SY; Kazanjian P; Delwart EL
    J Virol; 2004 Jul; 78(13):7112-23. PubMed ID: 15194787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of HIV-1 integrase gene polymorphism in an HIV-infected population from the nosocomial outbreak of HIV infection in the south of Russia in 1989].
    Gafarova IE; Shideeva ZhA; Sandzhieva DB; Garaev MM
    Vopr Virusol; 2010; 55(1):16-22. PubMed ID: 20364666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of primary lamivudine and nelfinavir resistance in HIV-1-infected pregnant women in the United States, 1998-2004.
    Paredes R; Cheng I; Kuritzkes DR; Tuomala RE
    AIDS; 2007 Oct; 21(15):2103-6. PubMed ID: 17885302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of drug resistance-associated mutations in treatment-naïve individuals infected with different genetic forms of HIV-1 circulating in countries of the former Soviet Union.
    Vázquez de Parga E; Rakhmanova A; Pérez-Alvarez L; Vinogradova A; Delgado E; Thomson MM; Casado G; Sierra M; Muñoz M; Carmona R; Vega Y; Contreras G; Medrano L; Osmanov S; Nájera R
    J Med Virol; 2005 Nov; 77(3):337-44. PubMed ID: 16173024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordant genotypic interpretation and phenotypic role of protease mutations in HIV-1 subtypes B and G.
    Santos AF; Abecasis AB; Vandamme AM; Camacho RJ; Soares MA
    J Antimicrob Chemother; 2009 Mar; 63(3):593-9. PubMed ID: 19136678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.